VTRS
VTRS
NASDAQ · Pharmaceuticals

Viatris Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$15.95
+0.03 (+0.19%)
As of Feb 24, 1:08 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 11 61%
Hold 5 28%
Sell 2 11%
Price Target
Analyst Price Target +670.0% upside
Low Target $69.38
Average Target $122.82
High Target $167.78
Current Price $15.95
Current
$15.95
Target
$122.82
$69.38 $122.82 avg $167.78
Scenario Analysis
Bear Case
$69.38
335.0%
Low target
Base Case
$122.82
+670.0%
Avg target
Bull Case
$167.78
+951.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$16.30
-2.1% from high
52-Week Low
$6.85
+132.8% from low
50-Day SMA
$13.14
+21.4% vs SMA
200-Day SMA
$10.55
+51.2% vs SMA
RSI (14)
87.6
Overbought
Target vs 52W High
$122.82
+653.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
 Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
 Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
 Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
 Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
 Buy 18 61% $122.82 +670.0%